Atlas Trials

A Phase I Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors

Clinical trial NCT05114759 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05114759
Sponsor
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Tumors
Start date
2022-01-04
Primary completion
2026-12-30
Enrollment
176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.